Amphastar Pharmaceuticals, Inc. — Director's Dealing 2018

Nov 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2018-11-28

Reporting Person: Liawatidewi Yakob (SVP Corp Admin Center)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-28	Common Stock	S	1520	$20.487	Disposed	8849	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	37463	Direct

Footnotes

F1: The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.